skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients

Guglielmelli, P ; Lasho, T L ; Rotunno, G ; Score, J ; Mannarelli, C ; Pancrazzi, A ; Biamonte, F ; Pardanani, A ; Zoi, K ; Reiter, A ; Duncombe, A ; Fanelli, T ; Pietra, D ; Rumi, E ; Finke, C ; Gangat, N ; Ketterling, R P ; Knudson, R A ; Hanson, C A ; Bosi, A ; Pereira, A ; Manfredini, R ; Cervantes, F ; Barosi, G ; Cazzola, M ; Cross, N C P ; Vannucchi, A M ; Tefferi, A

Leukemia, 2014-09, Vol.28 (9), p.1804-1810 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo
Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo
Material Type:
Artigo 		Adicionar ao Meu Espaço

Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo

OLIVIERI, A ; MARCHETTI, M ; LEMOLI, R ; TARELLA, C ; LACONE, A ; LANZA, F ; RAMBALDI, A ; BOSI, A

Bone marrow transplantation (Basingstoke), 2012-03, Vol.47 (3), p.342-351 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia

Ruggeri, A ; Labopin, M ; Sanz, G ; Piemontese, S ; Arcese, W ; Bacigalupo, A ; Blaise, D ; Bosi, A ; Huang, H ; Karakasis, D ; Koc, Y ; Michallet, M ; Picardi, A ; Sanz, J ; Santarone, S ; Sengelov, H ; Sierra, J ; Vincent, L ; Volt, F ; Nagler, A ; Gluckman, E ; Ciceri, F ; Rocha, V ; Mohty, M

Leukemia, 2015-09, Vol.29 (9), p.1891-1900 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value
Material Type:
Artigo 		Adicionar ao Meu Espaço

Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value

Vannucchi, A M ; Rotunno, G ; Bartalucci, N ; Raugei, G ; Carrai, V ; Balliu, M ; Mannarelli, C ; Pacilli, A ; Calabresi, L ; Fjerza, R ; Pieri, L ; Bosi, A ; Manfredini, R ; Guglielmelli, P

Leukemia, 2014-09, Vol.28 (9), p.1811-1818 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine
Material Type:
Artigo 		Adicionar ao Meu Espaço

Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine

Valencia, A ; Masala, E ; Rossi, A ; Martino, A ; Sanna, A ; Buchi, F ; Canzian, F ; Cilloni, D ; Gaidano, V ; Voso, M T ; Kosmider, O ; Fontenay, M ; Gozzini, A ; Bosi, A ; Santini, V

Leukemia, 2014-03, Vol.28 (3), p.621-628 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical implications of the JAK2 V617F mutation in essential thrombocythemia

Antonioli, E ; Guglielmelli, P ; Pancrazzi, A ; Bogani, C ; Verrucci, M ; Ponziani, V ; Longo, G ; Bosi, A ; Vannucchi, A M

Leukemia, 2005-10, Vol.19 (10), p.1847-1849 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden
Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden

Vannucchi, A M ; Antonioli, E ; Guglielmelli, P ; Longo, G ; Pancrazzi, A ; Ponziani, V ; Bogani, C ; Ferrini, P R ; Rambaldi, A ; Guerini, V ; Bosi, A ; Barbui, T

Leukemia, 2007-09, Vol.21 (9), p.1952-1959 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
8
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System
Material Type:
Artigo 		Adicionar ao Meu Espaço

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System

Della Porta, M G ; Jackson, C H ; Alessandrino, E P ; Rossi, M ; Bacigalupo, A ; van Lint, M T ; Bernardi, M ; Allione, B ; Bosi, A ; Guidi, S ; Santini, V ; Malcovati, L ; Ubezio, M ; Milanesi, C ; Todisco, E ; Voso, M T ; Musto, P ; Onida, F ; Iori, A P ; Cerretti, R ; Grillo, G ; Molteni, A ; Pioltelli, P ; Borin, L ; Angelucci, E ; Oldani, E ; Sica, S ; Pascutto, C ; Ferretti, V ; Santoro, A ; Bonifazi, F ; Cazzola, M ; Rambaldi, A

Leukemia, 2017-11, Vol.31 (11), p.2449-2457 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission
Material Type:
Artigo 		Adicionar ao Meu Espaço

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission

Saraceni, F ; Bruno, B ; Lemoli, R M ; Meloni, G ; Arcese, W ; Falda, M ; Ciceri, F ; Alessandrino, E P ; Specchia, G ; Scimè, R ; Raimondi, R ; Bacigalupo, A ; Bosi, A ; Onida, F ; Rambaldi, A ; Bonifazi, F ; Olivieri, A

Bone marrow transplantation (Basingstoke), 2017-01, Vol.52 (1), p.163-166 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk
FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk
Material Type:
Artigo 		Adicionar ao Meu Espaço

FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk

Spina, M. ; Nagy, Z. ; Ribera, J.M. ; Federico, M. ; Aurer, I. ; Jordan, K. ; Borsaru, G. ; Pristupa, A.S. ; Bosi, A. ; Grosicki, S. ; Glushko, N.L. ; Ristic, D. ; Jakucs, J. ; Montesinos, P. ; Mayer, J. ; Rego, E.M. ; Baldini, S. ; Scartoni, S. ; Capriati, A. ; Maggi, C.A. ; Simonelli, C.

Annals of oncology, 2015-10, Vol.26 (10), p.2155-2161 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (154)

Data de Publicação 

De até
Refinar
  1. Antes de1999  (8)
  2. 1999Até2006  (24)
  3. 2007Até2011  (43)
  4. 2012Até2017  (50)
  5. Após 2017  (36)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.